Why the study?
Does infusion of 1 g of aminophylline improve hemodynamic and respiratory parameters in patients with cor pulmonale due to chronic obstructive pulmonary disease?
Does infusion of 1 g of aminophylline improve hemodynamic and respiratory parameters in patients with cor pulmonale due to chronic obstructive pulmonary disease?
Aminophylline infusion significantly reduces pulmonary artery and ventricular end-diastolic pressures in patients with cor pulmonale due to COPD, likely via pulmonary arteriolar dilatation.
Answers are grounded in this paper and cite their sources.
May reduce pressures in cor pulmonale; hypothesis-generating and should not yet change practice.
Nine patients with cor pulmonale due to chronic obstructive pulmonary disease were studied by means of right and left heart catheterization. Hemodynamic and respiratory observations were made during a control period and during the infusion of 1 g of aminophylline. Aminophylline produced a significant reduction in mean pulmonary artery pressure from 39.4 to 25.4 mm Hg, in right ventricular end-diastolic pressure from 8.6 to 2.1 mm Hg, in left ventricular end-diastolic pressure from 7.9 to 3.0 mm Hg, and in brachial artery mean pressure from 95.3 to 85.6 mm Hg. The heart rate and oxygen consumption increased, but there was no change in cardiac index. The alveolar ventilation increased significantly from 2.1 to 2.9 L/min/m 2 (BTPS). Evidence is presented to suggest that the decrease in pulmonary artery pressure was due to pulmonary arteriolar dilatation.
No takes yet. Share an insight, caveat, or question.
Parker et al. (1966) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: